BioSilta

About:

BioSilta Ltd, a developer of advanced microbial growth systems,

Top Investors: Omega Funds, Inveni Capital

Description:

BioSilta Ltd. is a privately-held company that utilizes its unique, proprietary EnBase® technology platform to develop innovative, reagent-based EnPresso® growth systems. When compared to conventional growth media, EnPresso growth systems significantly increase the yield of high quality biomolecules from microbial cultures.

Total Funding Amount:

2.5M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Saint Ives, Cambridgeshire, United Kingdom

Founded Date:

2014-01-01

Founders:

Peter Neubauer

Number of Employees:

11-50

Last Funding Date:

2014-06-11

IPO Status:

Private

Industries: